世界のアルツハイマー検査機器開発動向:医療機器パイプライン分析2015...市場調査レポートについてご紹介

【英文タイトル】Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 17
2 Introduction 18
2.1 Alzheimer Diagnostic Tests Overview 18
3 Products under Development 19
3.1 Alzheimer – Pipeline Products by Stage of Development 19
3.2 Alzheimer – Pipeline Products by Territory 20
3.3 Alzheimer – Pipeline Products by Regulatory Path 21
3.4 Alzheimer – Pipeline Products by Estimated Approval Date 22
3.5 Alzheimer – Ongoing Clinical Trials 23
4 Alzheimer – Pipeline Products under Development by Companies 24
4.1 Alzheimer Companies – Pipeline Products by Stage of Development 24
4.2 Alzheimer – Pipeline Products by Stage of Development 29
5 Alzheimer Companies and Product Overview 34
5.1 AC Immune SA Company Overview 34
5.1.1 AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 34
5.2 Acobiom Company Overview 37
5.2.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 37
5.3 Acumen Pharmaceuticals, Inc. Company Overview 40
5.3.1 Acumen Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.4 Adlyfe Inc. Company Overview 42
5.4.1 Adlyfe Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.5 Advanced Genomic Technology, LLC Company Overview 43
5.5.1 Advanced Genomic Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 43
5.6 ADx NeuroSciences NV Company Overview 44
5.6.1 ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 44
5.7 Akrivis Technologies, LLC Company Overview 58
5.7.1 Akrivis Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 58
5.8 Alere Inc. Company Overview 59
5.8.1 Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.9 Alzhyme Pty Ltd Company Overview 61
5.9.1 Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
5.10 Amarantus Bioscience Holdings, Inc. Company Overview 62
5.10.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.11 Applied Proteomics, Inc. Company Overview 66
5.11.1 Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.12 Araclon Biotech, S.L. Company Overview 67
5.12.1 Araclon Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 67
5.13 Banyan Biomarkers, Inc. Company Overview 68
5.13.1 Banyan Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68
5.14 BioArctic Neuroscience AB Company Overview 69
5.14.1 BioArctic Neuroscience AB Pipeline Products & Ongoing Clinical Trials Overview 69
5.15 biOasis Technologies Inc. Company Overview 70
5.15.1 biOasis Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.16 Biomedical Development Corporation Company Overview 71
5.16.1 Biomedical Development Corporation Pipeline Products & Ongoing Clinical Trials Overview 71
5.17 BioSystems International Company Overview 72
5.17.1 BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 72
5.18 C2N Diagnostics LLC Company Overview 73
5.18.1 C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 73
5.19 Chronix Biomedical, Inc. Company Overview 74
5.19.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.20 Cognoptix, Inc. Company Overview 76
5.20.1 Cognoptix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 Columbia University Company Overview 80
5.21.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 80
5.22 CompanDX Ltd. Company Overview 83
5.22.1 CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83
5.23 Consejo Superior de Investigaciones Cientificas Company Overview 84
5.23.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 84
5.24 Cymedx Company Overview 86
5.24.1 Cymedx Pipeline Products & Ongoing Clinical Trials Overview 86
5.25 DiaGenic ASA Company Overview 87
5.25.1 DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview 87
5.26 DiamiR LLC Company Overview 94
5.26.1 DiamiR LLC Pipeline Products & Ongoing Clinical Trials Overview 94
5.27 DiaPat GmbH Company Overview 95
5.27.1 DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 95
5.28 Diaxonhit S.A. Company Overview 96
5.28.1 Diaxonhit S.A. Pipeline Products & Ongoing Clinical Trials Overview 96
5.29 Dr. Grossegger & Drbal GmbH Company Overview 97
5.29.1 Dr. Grossegger & Drbal GmbH Pipeline Products & Ongoing Clinical Trials Overview 97
5.30 DS Pharma Biomedical Co., Ltd. Company Overview 98
5.30.1 DS Pharma Biomedical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 Durin Technologies, Inc. Company Overview 99
5.31.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
5.32 Emory University Company Overview 100
5.32.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 100
5.33 Fianostics GmbH Company Overview 101
5.33.1 Fianostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 101
5.34 Gene Solutions LLC Company Overview 102
5.34.1 Gene Solutions LLC Pipeline Products & Ongoing Clinical Trials Overview 102
5.35 GeneNews Limited Company Overview 103
5.35.1 GeneNews Limited Pipeline Products & Ongoing Clinical Trials Overview 103
5.36 Genentech, Inc. Company Overview 105
5.36.1 Genentech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 Georg-August-Universitat Gottingen Company Overview 107
5.37.1 Georg-August-Universitat Gottingen Pipeline Products & Ongoing Clinical Trials Overview 107
5.38 Ghent University Company Overview 110
5.38.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 110
5.39 HealthTell, Inc. Company Overview 111
5.39.1 HealthTell, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.40 ICDD-sas Company Overview 112
5.40.1 ICDD-sas Pipeline Products & Ongoing Clinical Trials Overview 112
5.41 Innovative California Biosciences International, Inc. Company Overview 115
5.41.1 Innovative California Biosciences International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 115
5.42 Innovative Health Diagnostics Company Overview 122
5.42.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 122
5.43 Institut National de la Sante et de la Recherche Medicale Company Overview 123
5.43.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 123
5.44 Instituto de Estructura de la Materia Company Overview 124
5.44.1 Instituto de Estructura de la Materia Pipeline Products & Ongoing Clinical Trials Overview 124
5.45 Integrated Diagnostics Inc. Company Overview 125
5.45.1 Integrated Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.46 Janssen Pharmaceutica N.V. Company Overview 126
5.46.1 Janssen Pharmaceutica N.V. Pipeline Products & Ongoing Clinical Trials Overview 126
5.47 KineMed, Inc. Company Overview 127
5.47.1 KineMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.48 Laboratory Corporation of America Holdings Company Overview 128
5.48.1 Laboratory Corporation of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 128
5.49 McGill University Health Center Company Overview 130
5.49.1 McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview 130
5.50 Memory Dx, LLC Company Overview 131
5.50.1 Memory Dx, LLC Pipeline Products & Ongoing Clinical Trials Overview 131
5.51 Meso Scale Diagnostics LLC Company Overview 132
5.51.1 Meso Scale Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 132
5.52 Myriad Genetics, Inc. Company Overview 133
5.52.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.53 NanoSomiX, Inc. Company Overview 135
5.53.1 NanoSomiX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.54 Nanosphere, Inc. Company Overview 137
5.54.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 137
5.55 Neuron Biopharma SA Company Overview 139
5.55.1 Neuron Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 139
5.56 NeuroQuest, Ltd. Company Overview 141
5.56.1 NeuroQuest, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 141
5.57 Neurotrope Bioscience, Inc. Company Overview 142
5.57.1 Neurotrope Bioscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
5.58 NeuroVision Imaging LLC. Company Overview 143
5.58.1 NeuroVision Imaging LLC. Pipeline Products & Ongoing Clinical Trials Overview 143
5.59 Newcastle University Company Overview 144
5.59.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 144
5.60 NextGen Sciences Dx Inc Company Overview 146
5.60.1 NextGen Sciences Dx Inc Pipeline Products & Ongoing Clinical Trials Overview 146
5.61 Novel Bio-spectrum Technologies, Inc. Company Overview 147
5.61.1 Novel Bio-spectrum Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.62 Oligomerix, inc. Company Overview 148
5.62.1 Oligomerix, inc. Pipeline Products & Ongoing Clinical Trials Overview 148
5.63 OPKO Health, Inc. Company Overview 149
5.63.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 149
5.64 Orasi Medical, Inc. Company Overview 152
5.64.1 Orasi Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
5.65 Oregon Health & Science University Company Overview 156
5.65.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 156
5.66 Oryzon Genomics S.A. Company Overview 157
5.66.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 157
5.67 Oxford Biodynamics Limited Company Overview 159
5.67.1 Oxford Biodynamics Limited Pipeline Products & Ongoing Clinical Trials Overview 159
5.68 PDx BioTech Company Overview 161
5.68.1 PDx BioTech Pipeline Products & Ongoing Clinical Trials Overview 161
5.69 PeriRx LLC Company Overview 162
5.69.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 162
5.70 Pre Diagnostics AS Company Overview 163
5.70.1 Pre Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 163
5.71 Predemtec GmbH Company Overview 164
5.71.1 Predemtec GmbH Pipeline Products & Ongoing Clinical Trials Overview 164
5.72 ProMIS Neurosciences Inc. Company Overview 165
5.72.1 ProMIS Neurosciences Inc. Pipeline Products & Ongoing Clinical Trials Overview 165
5.73 Proplex Technologies, Llc Company Overview 167
5.73.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview 167
5.74 Protagen AG Company Overview 169
5.74.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 169
5.75 Proteome Sciences Plc Company Overview 170
5.75.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 170
5.76 Proteomics International Pty Ltd Company Overview 173
5.76.1 Proteomics International Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 173
5.77 Quanterix Corporation Company Overview 174
5.77.1 Quanterix Corporation Pipeline Products & Ongoing Clinical Trials Overview 174
5.78 Redox Diagnostics LLC Company Overview 175
5.78.1 Redox Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 175
5.79 Saladax Biomedical, Inc. Company Overview 176
5.79.1 Saladax Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 176
5.80 Satoris, Inc. Company Overview 177
5.80.1 Satoris, Inc. Pipeline Products & Ongoing Clinical Trials Overview 177
5.81 Scout Diagnostics, LLC Company Overview 178
5.81.1 Scout Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview 178
5.82 Singulex, Inc. Company Overview 179
5.82.1 Singulex, Inc. Pipeline Products & Ongoing Clinical Trials Overview 179
5.83 SomaLogic, Inc. Company Overview 180
5.83.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 180
5.84 Takeda Pharmaceuticals International AG Company Overview 181
5.84.1 Takeda Pharmaceuticals International AG Pipeline Products & Ongoing Clinical Trials Overview 181
5.85 The Johns Hopkins University Company Overview 183
5.85.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183
5.86 The University of Melbourne Company Overview 184
5.86.1 The University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview 184
5.87 Trinity College Dublin Company Overview 185
5.87.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 185
5.88 True Diagnostics, Inc. Company Overview 186
5.88.1 True Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
5.89 University of California, Irvine Company Overview 187
5.89.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 187
5.90 University of Chicago Company Overview 188
5.90.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 188
5.91 University of Georgia Company Overview 189
5.91.1 University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 189
5.92 University of Luxembourg Company Overview 190
5.92.1 University of Luxembourg Pipeline Products & Ongoing Clinical Trials Overview 190
5.93 University of Nottingham Company Overview 191
5.93.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 191
5.94 University of South Florida Company Overview 192
5.94.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 192
5.95 University of Texas Health Science Center at Houston Company Overview 193
5.95.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 193
5.96 University of Texas Southwestern Medical Center at Dallas Company Overview 195
5.96.1 University of Texas Southwestern Medical Center at Dallas Pipeline Products & Ongoing Clinical Trials Overview 195
5.97 US Biomarkers, Inc. Company Overview 197
5.97.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
5.98 Vermillion, Inc. Company Overview 198
5.98.1 Vermillion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 198
5.99 Vitruvian Biomedical, Inc. Company Overview 200
5.99.1 Vitruvian Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 200
5.100 Washington University in St. Louis Company Overview 201
5.100.1 Washington University in St. Louis Pipeline Products & Ongoing Clinical Trials Overview 201
5.101 XRGenomics LTD Company Overview 205
5.101.1 XRGenomics LTD Pipeline Products & Ongoing Clinical Trials Overview 205
5.102 Zoiray Technologies Inc. Company Overview 206
5.102.1 Zoiray Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 206
6 Alzheimer- Recent Developments 207
7 Appendix 213
7.1 Methodology 213
7.2 About GlobalData 215
7.3 Contact Us 216
7.4 Disclaimer 216


【レポート販売概要】

■ タイトル:世界のアルツハイマー検査機器開発動向:医療機器パイプライン分析2015
■ 英文:Alzheimer Diagnostic Tests - Medical Devices Pipeline Assessment, 2015
■ 発行日:2016年1月5日
■ 調査会社:GlobalData
■ 商品コード:GDME0143EPD
■ 調査対象地域:グローバル
  • 油圧ユニットの世界市場
    The Hydraulic Power Unit (HPU) is an integrated package comprising hydraulic motor, hydraulic pump, and reservoir/accumulators along with other accessories such as valves, tubes, filter, regulators, and instruments to monitor the performance of a unit. It is used to transmit, control, and distribute energy from a pressurized fluid to perform various mechanical tasks. It is the main component of hy …
  • グローバルIT産業の景況感レポート(2015年上半期)
    Summary “IT Industry Business Confidence Report H1 2015” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the IT industry. This report also examines executive opinions with regards to the current and future state of the economy and its effect on the IT industry. It anal …
  • アドバンストセラミックスの世界市場:アルミナセラミックス、チタン酸鉛セラミックス、 ジルコニアセラミックス、炭化けい素セラミックス
    About Advanced Ceramics Advanced ceramics are mainly produced by controlled crystallization of certain chemicals, generally induced by nucleating additives. They are made of nitrates, carbides, oxides, and other materials using modern processing technologies. These ceramics are hard, durable, wear resistant, corrosion resistant, and have different electrical properties. The properties of these cer …
  • 通信サービス保証の世界市場予測(~2021年)
    The telecom service assurance market is expected to grow from USD 4.30 Billion in 2016 to USD 7.01 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 10.3% during the forecast period. The voluminous increase in the number of subscribers, need for high optimization & increased cost savings, and ability to measure the performance of a service & Quality of Service (QoS) have led to the incre …
  • 世界のEV走行用モータ市場2015
    The Global EV Traction Motor Industry Report 2015 is a professional and in-depth study on the current state of the EV Traction Motor industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The EV Traction Motor market analysis is provided for the international markets including development trends, competitive …
  • 血液培養テストの世界市場:方式(自動、手動)、製品(消耗品、装置)、技術、用途、エンドユーザー、地域別分析
    The global blood culture tests market is projected to reach USD 4,768.9 Million by 2021 from USD 3,252.6 Million in 2016, at a CAGR of 8.0%. Factors such as increasing number of sepsis cases and high cost of treatment, rising geriatric population, growing number of product approvals, high incidence of bloodstream infections, growth in demand for rapid diagnostic techniques, and high prevalence of …
  • ジオグリッドの世界市場予測(~2022年):種類、用途、製造方法、地域別分析
    The geogrid market is projected to reach USD 1099.2 Million by 2022, at a CAGR of 9.2% from 2017 to 2022. The growth of this market can be attributed to the rising use of geogrids in the emerging economies. In addition, increased cost savings achieved in road construction and maintenance activities with the use of geogrids is also anticipated to drive the geogrid market. Geogrids are used for vari …
  • ウォータースポーツ用品・装具の世界市場2016-2020:水中スポーツ用品、水上スポーツ用品
    About Water Sports Gear and Equipment Water sports gear and equipment include gear and equipment for any sports activity conducted in water, under water, and on water. The global water sports gear and equipment market is expected to grow at a CAGR of 5.37% during the forecast period. This growth can be attributed to the increasing interest for water tourism, including sailing and boating. Technavi …
  • ウィルムス腫瘍 (腎芽細胞腫):グローバル臨床試験レビューH2, 2013
    Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H2, 2013" provides data on the Wilms’ Tumor (Nephroblastoma) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wilms’ Tumor (Nephroblastoma). It includes an overv …
  • 健康保険の世界市場:プロバイダー別、保険種類別、カバレッジタイプ別、人口統計別、ネットワーク別
    The global health insurance market was valued at $3,153 billion in 2018, and is estimated to reach $4,475 billion by 2026, registering a CAGR of 4.4% from 2019 to 2026. Health insurance covers various Health expenses, including the routine of health examinations, unforeseen illnesses or injuries, inpatient & outpatient surgery, specialist referral visits, and prescription medications of insured pe …
  • 世界の原子力発電所及び装置市場(~2019)
    This report estimates the nuclear power and equipment market in terms of value. The market is estimated on the basis of the global upcoming nuclear power plant countfor the period 2012 to 2019.The market value is estimated on the basis of the capital expenditures ofthe various types of nuclear power plants. The report estimates the market size of nuclear power reactorsfor products comprising PWR a …
  • 膝置換術用機器の世界市場2017-2021
    About Knee Replacement Devices Knee replacement is a surgical procedure, which is performed to replace a damaged part of the knee through knee replacement devices. This procedure is generally performed on patients with osteoarthritis, rheumatoid arthritis, and obesity-related knee problems. Technavio’s analysts forecast the global Knee Replacement Devices market to grow at a CAGR of 3.25% during t …
  • オーラルケアの世界市場分析:歯ブラシ、歯みがき、マウスウォッシュ、リンス、総義歯、デンタル付属品
    The global oral care market is anticipated to reach USD 40.92 billion by 2025, according to a new report by Grand View Research, Inc. Growing awareness among people regarding oral hygiene and increasing incidence of dental caries has led to high growth of the market. Awareness about dental hygiene is increasing among people of both developed as well as developing regions. Various awareness program …
  • 事業提携・ライセンシング・投資・M&A動向:September 2013(製薬業界)
    Partnerships, Licensing, Investments and M&A Deals and Trends for September 2013 in Pharmaceuticals Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for September 2013 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report p …
  • 飼料工場市場:カンボジア
    This report is a comprehensive research of feed mill industry in Cambodia. The first two chapters of the report feature the country profile by giving general information on Cambodia and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closi …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。